DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	14.06T
Revenue (ttm)	4.82T
Net Income (ttm)	796.24B
Shares Out	130.75M
EPS (ttm)	6,089.52
PE Ratio	17.65
Forward PE	16.17
Dividend	7,500.00 (6.98%)
Ex-Dividend Date	May 23, 2025

Volume	40,732
Average Volume	33,750
Open	108,100
Previous Close	107,500
Day's Range	105,100 - 108,400
52-Week Range	87,000 - 125,900
Beta	0.37
RSI	70.28
Earnings Date	Apr 18, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.